SCHEMBL5412

SCHEMBL5412

CC(C)C1CCCCCC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.48
EPHX1 P07099 2/20 0.41
TP53 P04637 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
MMP2 P08253 2/20 0.37
CA9 Q16790 2/20 0.37
KDM4E B2RXH2 1/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21575869 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL5132 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL8022524 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL5282 1.00
SCHEMBL3335831 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL28542817 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL7739164 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
Cyclohexane SCHEMBL5321429 1.00 SHBG (0.48) SHBGEPHX1TP53ALDH1A1HSD17B10
Water SCHEMBL9224817 0.97 SHBG (0.46) SHBGEPHX1TP53ALDH1A1HSD17B10
SCHEMBL140725 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10781149-B2 Transalkylation process EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-09-22 US claimed
CN-109647199-A A kind of preparation method of reverse osmosis membrane and thus obtained reverse osmosis membrane 时代沃顿科技有限公司 2019-04-19 CN claimed
US-20160176787-A1 Transalkylation Process EXXONMOBIL CHEMICAL PATENTS INC. 2016-06-23 US claimed
CN-105694028-A Interfacial polymeric oil-phase reaction composition for preparing composite reverse osmosis membranes and use method thereof 贵阳时代沃顿科技有限公司 2016-06-22 CN claimed
US-9057951-B2 Chemically amplified photoresist composition and process for its use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-06-16 US claimed
WO-2013173332-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN Vertichem Corporation (CA) 2013-11-21 WO claimed
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
WO-2013134756-A1 A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN Vertichem Corporation (CA) 2013-09-12 WO claimed
WO-2011023497-A1 CHEMICALLY AMPLIFIED PHOTORESIST COMPOSITION AND PROCESS FOR ITS USE INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-03-03 WO claimed
US-20240172465-A1 LIGHT-EMITTING DEVICE, DISPLAY DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-05-23 US disclosed
CN-117956818-A Light emitting device, display device, and electronic apparatus 株式会社半导体能源研究所 2024-04-30 CN disclosed
CN-117631446-A Resist composition and use thereof 张斌 2024-03-01 CN disclosed
WO-2023225664-A1 LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF DICE ALPHA, INC. (US) 2023-11-23 WO disclosed
US-20230282772-A1 LIGHT-EMITTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-07 US disclosed
US-4619782-A L-aminodicarboxylic acid gem-diamines GENERAL FOODS CORPORATION (US) 1986-10-28 US disclosed
EP-0186173-A2 L-Aminodicarboxylic-(0-cycloalkyl)-L-aminocarboxylate alkyl esters, an edible composition containing same as sweeteners and a method for sweetening an edible composition GENERAL FOODS CORPORATION (US) 1986-07-02 EP disclosed
US-4572799-A L-Aminodicarboxylic acid amides GENERAL FOODS CORPORATION (US) 1986-02-25 US disclosed
US-4358563-A MOLDING MATERIALS OF IMPROVED IMPACT STRENGTH GENERAL ELECTRIC COMPANY (US) 1982-11-09 US disclosed
US-3992451-A IN THE PRESENCE OF FREE RADICAL CATALYSTS, HYDROGEN CHLORIDE, AND CARBON MONOXIDE UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN DCXR, AGL, GLO1 SHBG 1970/4885EPHX1 786/4885TP53 3477/4885
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN HAAO, HAO2, HACL2 SHBG 3011/4885EPHX1 241/4885TP53 3634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.